<DOC>
	<DOCNO>NCT00362232</DOCNO>
	<brief_summary>The purpose study assess 10 mg BAY59-7939 , take daily tablet , safe prevents blood clot may form knee replacement operation .</brief_summary>
	<brief_title>Regulation Coagulation Orthopedic Surgery Prevent Deep Vein Thromboembolism ( DVT ) Pulmonary Embolism ( PE ) . A Study BAY59-7939 Prevention Venous Thrombo Embolism ( VTE ) Subjects Undergoing Elective Total Knee Replacement .</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Male female patient age 18 year Patients schedule elective total knee replacement Active bleeding high risk bleed contraindicate treatment Low Molecular Weight Heparin ( LMWH ) Contraindication list label condition preclude subject treatment enoxaparin require dose adjustment ( e.g . severe renal impairment , please refer local label enoxaparin country ) Conditions prohibit bilateral venography ( e.g . amputation 1 leg , allergy contrast medium )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Prevention venous thromboembolism</keyword>
</DOC>